What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

BACKGROUND: Mammary analogue secretory carcinoma (MASC) is a recently described pathologic entity. We report the case of a patient with an initial diagnosis of salivary acinic cell carcinoma later reclassified as MASC after next-generation sequencing revealed an ETV6-NTRK3 fusion. PATIENTS AND METHO...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Oncol
Auteurs principaux: Drilon, A., Li, G., Dogan, S., Gounder, M., Shen, R., Arcila, M., Wang, L., Hyman, D. M., Hechtman, J., Wei, G., Cam, N. R., Christiansen, J., Luo, D., Maneval, E. C., Bauer, T., Patel, M., Liu, S. V., Ou, S. H. I., Farago, A., Shaw, A., Shoemaker, R. F., Lim, J., Hornby, Z., Multani, P., Ladanyi, M., Berger, M., Katabi, N., Ghossein, R., Ho, A. L.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843186/
https://ncbi.nlm.nih.gov/pubmed/26884591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw042
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires